vs

Side-by-side financial comparison of Clearwater Paper Corp (CLW) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

Clearwater Paper Corp is the larger business by last-quarter revenue ($360.3M vs $186.7M, roughly 1.9× NEOGENOMICS INC). Clearwater Paper Corp runs the higher net margin — -3.6% vs -57.9%, a 54.3% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs -4.7%). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs 2.3%).

Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

CLW vs NEO — Head-to-Head

Bigger by revenue
CLW
CLW
1.9× larger
CLW
$360.3M
$186.7M
NEO
Growing faster (revenue YoY)
NEO
NEO
+15.8% gap
NEO
11.1%
-4.7%
CLW
Higher net margin
CLW
CLW
54.3% more per $
CLW
-3.6%
-57.9%
NEO
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
2.3%
CLW

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLW
CLW
NEO
NEO
Revenue
$360.3M
$186.7M
Net Profit
$-12.8M
$-108.0M
Gross Margin
-0.2%
43.3%
Operating Margin
46.9%
Net Margin
-3.6%
-57.9%
Revenue YoY
-4.7%
11.1%
Net Profit YoY
-103.2%
42.0%
EPS (diluted)
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLW
CLW
NEO
NEO
Q1 26
$360.3M
$186.7M
Q4 25
$386.4M
$190.2M
Q3 25
$399.0M
$187.8M
Q2 25
$391.8M
$181.3M
Q1 25
$378.2M
$168.0M
Q4 24
$387.1M
$172.0M
Q3 24
$393.3M
$167.8M
Q2 24
$344.4M
$164.5M
Net Profit
CLW
CLW
NEO
NEO
Q1 26
$-12.8M
$-108.0M
Q4 25
$38.3M
Q3 25
$-53.3M
$-27.1M
Q2 25
$2.7M
$-45.1M
Q1 25
$-6.3M
$-25.9M
Q4 24
$199.1M
Q3 24
$5.8M
$-17.7M
Q2 24
$-25.8M
$-18.6M
Gross Margin
CLW
CLW
NEO
NEO
Q1 26
-0.2%
43.3%
Q4 25
4.5%
43.8%
Q3 25
4.7%
42.8%
Q2 25
11.0%
42.6%
Q1 25
9.7%
43.6%
Q4 24
3.8%
44.9%
Q3 24
7.7%
44.6%
Q2 24
-0.6%
44.1%
Operating Margin
CLW
CLW
NEO
NEO
Q1 26
46.9%
Q4 25
1.9%
-7.1%
Q3 25
-13.9%
-14.4%
Q2 25
2.5%
-26.3%
Q1 25
-1.1%
-16.6%
Q4 24
-4.0%
-10.7%
Q3 24
-0.3%
-12.6%
Q2 24
-13.6%
-13.3%
Net Margin
CLW
CLW
NEO
NEO
Q1 26
-3.6%
-57.9%
Q4 25
9.9%
Q3 25
-13.4%
-14.4%
Q2 25
0.7%
-24.9%
Q1 25
-1.7%
-15.4%
Q4 24
51.4%
Q3 24
1.5%
-10.5%
Q2 24
-7.5%
-11.3%
EPS (diluted)
CLW
CLW
NEO
NEO
Q1 26
$-0.13
Q4 25
$2.36
Q3 25
$-3.30
Q2 25
$0.17
Q1 25
$-0.38
Q4 24
$11.87
Q3 24
$0.35
Q2 24
$-1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLW
CLW
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$36.5M
$146.1M
Total DebtLower is stronger
$361.1M
Stockholders' EquityBook value
$813.8M
$828.8M
Total Assets
$1.6B
$1.3B
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLW
CLW
NEO
NEO
Q1 26
$36.5M
$146.1M
Q4 25
$30.7M
$159.6M
Q3 25
$34.4M
$164.1M
Q2 25
$46.7M
$154.7M
Q1 25
$44.0M
$346.2M
Q4 24
$79.6M
$367.0M
Q3 24
$35.5M
$362.0M
Q2 24
$39.6M
$355.1M
Total Debt
CLW
CLW
NEO
NEO
Q1 26
$361.1M
Q4 25
$346.8M
$341.9M
Q3 25
$337.0M
Q2 25
$330.1M
Q1 25
Q4 24
$283.4M
$541.1M
Q3 24
$1.2B
Q2 24
$1.1B
Stockholders' Equity
CLW
CLW
NEO
NEO
Q1 26
$813.8M
$828.8M
Q4 25
$825.3M
$836.6M
Q3 25
$783.0M
$838.3M
Q2 25
$836.8M
$854.0M
Q1 25
$836.6M
$888.3M
Q4 24
$854.6M
$902.3M
Q3 24
$664.6M
$908.2M
Q2 24
$658.6M
$915.9M
Total Assets
CLW
CLW
NEO
NEO
Q1 26
$1.6B
$1.3B
Q4 25
$1.6B
$1.4B
Q3 25
$1.6B
$1.4B
Q2 25
$1.6B
$1.4B
Q1 25
$1.6B
$1.6B
Q4 24
$1.7B
$1.6B
Q3 24
$2.5B
$1.6B
Q2 24
$2.5B
$1.6B
Debt / Equity
CLW
CLW
NEO
NEO
Q1 26
0.44×
Q4 25
0.42×
0.41×
Q3 25
0.43×
Q2 25
0.39×
Q1 25
Q4 24
0.33×
0.60×
Q3 24
1.73×
Q2 24
1.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLW
CLW
NEO
NEO
Operating Cash FlowLast quarter
$-8.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLW
CLW
NEO
NEO
Q1 26
$-8.1M
Q4 25
$5.0M
$1.3M
Q3 25
$34.0M
$8.9M
Q2 25
$-28.2M
$20.3M
Q1 25
$1.5M
$-25.3M
Q4 24
$-35.1M
$9.8M
Q3 24
$16.2M
$9.2M
Q2 24
$21.1M
$13.9M
Free Cash Flow
CLW
CLW
NEO
NEO
Q1 26
Q4 25
$-9.9M
$-6.5M
Q3 25
$15.7M
$570.0K
Q2 25
$-51.1M
$14.0M
Q1 25
$-31.2M
$-29.8M
Q4 24
$-68.1M
$-1.8M
Q3 24
$-30.8M
$-1.6M
Q2 24
$3.0M
$814.0K
FCF Margin
CLW
CLW
NEO
NEO
Q1 26
Q4 25
-2.6%
-3.4%
Q3 25
3.9%
0.3%
Q2 25
-13.0%
7.7%
Q1 25
-8.2%
-17.8%
Q4 24
-17.6%
-1.0%
Q3 24
-7.8%
-0.9%
Q2 24
0.9%
0.5%
Capex Intensity
CLW
CLW
NEO
NEO
Q1 26
Q4 25
3.9%
4.1%
Q3 25
4.6%
4.4%
Q2 25
5.8%
3.5%
Q1 25
8.6%
2.7%
Q4 24
8.5%
6.7%
Q3 24
12.0%
6.4%
Q2 24
5.3%
8.0%
Cash Conversion
CLW
CLW
NEO
NEO
Q1 26
Q4 25
0.13×
Q3 25
Q2 25
-10.44×
Q1 25
Q4 24
-0.18×
Q3 24
2.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons